A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma

NCT01913119 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Histologically Proven Extranodal NKTcell Lymphoma

Interventions

DRUG: Romidepsin

Sponsor

Samsung Medical Center

Collaborators

[object Object]